Trial
NCT02769169
Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sun Yat-sen University
Collaborators
—
Condition
Polypoidal Choroidal Vasculopathy
Intervention
Lucentis® (Raibizumab) double-dose
Why stopped
study protocol changed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-19